Your industry news - first Number 1 for Recruitment
We strongly recommend viewing Cleanzine full size in your web browser. Click our masthead above to visit our website version.
Tru-D SmartUVC added to hospital's arsenal of infection prevention protocols
Mission Hospital, a Californian-based member of the US St. Joseph Hoag Health network, has added a new layer of proactive protection against the spread of infections in its facility. In addition to stringent manual cleaning processes by the facility's environmental care services (EVS) team, it has adopted Tru-D SmartUVC, a UV disinfection robot, to provide terminal room disinfection once the EVS staff performs manual cleaning protocols.
"Mission Hospital is committed to providing the highest level of patient care possible in the cleanest health care environment possible," says Tarek Salaway, chief executive at Mission Hospital. "The investment of this technology is one of many ways that we are working to safeguard the well-being of every single patient who walks through our doors and protect the integrity of our health care environment."
UV disinfection has been proven by multiple studies as an effective, chemical-free way to rid the environment of harmful pathogens such as C. diff, MRSA, VRE and more. In fact, the recently published Benefits of Enhanced Terminal Room-Disinfection (BETR-D) study results showed that Tru-D reduced the risk of acquisition and infection of target multidrug-resistant organisms among patients admitted to the same room by a cumulative 30%.
After traditional cleaning methods are performed, Tru-D is rolled in to the room to complete the disinfection process. Activated by remote control outside the room, Tru-D operates from one position and administers a single cycle of UV light. Using patented Sensor360 technology, it compensates for room variables such as size, shape and contents, taking whatever time is necessary to disinfect the room. Once the cycle is complete, the operator is notified via audio and/or text message and can be moved to the next room.
"Tru-D has been validated by more than a dozen, independent, third-party studies to show that it is capable of reducing the spread of infectious diseases," reports Chuck Dunn, CEO and president of Tru-D SmartUVC.
"Due to Tru-D's Sensor360 technology, it was the only device chosen for the first-ever randomised clinical trial on UV disinfection, which was funded by the Centers for Disease Control & Prevention and conducted by Duke Health."
26th January 2017